摘要 |
The invention provides novel reagents, kits, and methods for diagnosis of predisposition to low spine bone mineral density, low total hip bone mineral density, low femoral neck bone mineral density, or osteoporosis, based on analysis of polymorphic variants of the nucleic acid set forth in SEQ ID NO:1. |